Pentazocine {D.D.} en es it fr

Pentazocine {D.D.} Brand names, Pentazocine {D.D.} Analogs

Pentazocine {D.D.} Brand Names Mixture

  • No information avaliable

Pentazocine {D.D.} Chemical_Formula


Pentazocine {D.D.} RX_link

Pentazocine {D.D.} fda sheet

Pentazocine {D.D.} msds (material safety sheet)

Pentazocine_{D.D.} MSDS

Pentazocine {D.D.} Synthesis Reference

No information avaliable

Pentazocine {D.D.} Molecular Weight

285.424 g/mol

Pentazocine {D.D.} Melting Point

146.3 oC

Pentazocine {D.D.} H2O Solubility

No information avaliable

Pentazocine {D.D.} State


Pentazocine {D.D.} LogP


Pentazocine {D.D.} Dosage Forms

Liquid; Solution; Tablet

Pentazocine {D.D.} Indication

For the relief of moderate to severe pain

Pentazocine {D.D.} Pharmacology

Pentazocine is an opiate antagonist and prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension. Also, it can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine. Pentazocine is an essentially pure narcotic antagonist, i.e., it does not possess the "agonistic" or morphine-like properties characteristic of other narcotic antagonists; Pentazocine does not produce respiratory depression, psychotomimetic effects or pupillary constriction. In the absence of narcotics or agonistic effects of other narcotic antagonists, it exhibits essentially no pharmacologic activity.

Pentazocine {D.D.} Absorption

Well absorbed from the gastro-intestinal tract

Pentazocine {D.D.} side effects and Toxicity

No information avaliable

Pentazocine {D.D.} Patient Information

No information avaliable

Pentazocine {D.D.} Organisms Affected

Humans and other mammals